Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W J Huizinga

Showing results (41-50 of 234) with videos related to

Pageof 24
Sort By:
Annals of the Rheumatic Diseases|December 21, 2006
FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch CaucasiansMohamed M Thabet, J Wesoly, P E Slagboom, et al.
Arthritis Care & Research|September 14, 2012
Risk factors for progression in hand osteoarthritis: a systematic reviewW Y Kwok, J W M Plevier, F R Rosendaal, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Limitations in daily activities are the major determinant of reduced health-related quality of life in patients with hand osteoarthritisW Y Kwok, T P M Vliet Vlieland, F R Rosendaal, et al.
Clinical and Experimental Rheumatology|December 15, 2007
RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitroM M C Steenvoorden, R E M Toes, H K Ronday, et al.
Rheumatology (Oxford, England)|March 15, 2006
How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?P van Winkelen, J S van Denderen, C Y Vossen, et al.
Osteoarthritis and Cartilage|January 30, 2013
Association study of candidate genes for the progression of hand osteoarthritisJ Bijsterbosch, M Kloppenburg, M Reijnierse, et al.
Seminars in Arthritis and Rheumatism|November 22, 2023
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysisL van Ouwerkerk, S A Bergstra, T D Maarseveen, et al.
Arthritis Research & Therapy|March 10, 2017
Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritisT W J Huizinga, A Batalov, R Stoilov, et al.
Annals of the Rheumatic Diseases|April 19, 2005
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritisI Tchetverikov, L S Lohmander, N Verzijl, et al.
The Netherlands Journal of Medicine|July 30, 2015
Susac syndrome: a report of four cases and a review of the literatureS M van der Kooij, M A van Buchem, O M Overbeek, et al.
Pageof 24

Showing results (41-50 of 234) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|December 21, 2006
FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch CaucasiansMohamed M Thabet, J Wesoly, P E Slagboom, et al.
Arthritis Care & Research|September 14, 2012
Risk factors for progression in hand osteoarthritis: a systematic reviewW Y Kwok, J W M Plevier, F R Rosendaal, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Limitations in daily activities are the major determinant of reduced health-related quality of life in patients with hand osteoarthritisW Y Kwok, T P M Vliet Vlieland, F R Rosendaal, et al.
Clinical and Experimental Rheumatology|December 15, 2007
RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitroM M C Steenvoorden, R E M Toes, H K Ronday, et al.
Rheumatology (Oxford, England)|March 15, 2006
How evidence-based are advertisements in journals regarding the subspecialty of rheumatology?P van Winkelen, J S van Denderen, C Y Vossen, et al.
Osteoarthritis and Cartilage|January 30, 2013
Association study of candidate genes for the progression of hand osteoarthritisJ Bijsterbosch, M Kloppenburg, M Reijnierse, et al.
Seminars in Arthritis and Rheumatism|November 22, 2023
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world data analysisL van Ouwerkerk, S A Bergstra, T D Maarseveen, et al.
Arthritis Research & Therapy|March 10, 2017
Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritisT W J Huizinga, A Batalov, R Stoilov, et al.
Annals of the Rheumatic Diseases|April 19, 2005
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritisI Tchetverikov, L S Lohmander, N Verzijl, et al.
The Netherlands Journal of Medicine|July 30, 2015
Susac syndrome: a report of four cases and a review of the literatureS M van der Kooij, M A van Buchem, O M Overbeek, et al.
Pageof 24